BioCentury
ARTICLE | Clinical News

Lamisil terbinafine hydrochloride regulatory update

October 8, 2007 7:00 AM UTC

FDA approved an oral granule formulation of Lamisil terbinafine to treat tinea capitis (ringword of the scalp) in children aged 4 and up. NVS already markets the synthetic allylamine antifungal to tre...